A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Conditions
NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma · Adenocarcinoma of Esophagus · Squamous Cell Car. - Esophagus · Urothelial Carcinoma (UC) · Bladder Cancer · Mesothelioma · Pleural Mesothelioma · Peritoneal Mesothelioma · Non-Small Cell Lung Cancer NSCLC · Pancreatic Cancer · Biliary Tract Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Providence Medical Foundation, Santa Rosa, California, United States
Johns Hopkins Sibley Memorial Hospital, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Mahlet Atnafu) · SibleyOncResReferral@live.johnshopkins.edu · 202-669-6500Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida, United States
Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Study coordinator (Lindsey Becker, Primary Study Coordinator) · lbecker@nebraskacancer.com · 402-691-5255START Astera, LLC, East Brunswick, New Jersey, United States
Columbia University Irving Medical Center, New York, New York, United States
Contact: Study coordinator (Nurse Navigation Team: Contact for All Patient Referrals) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
START Dallas Fort Worth, Fort Worth, Texas, United States
MD Anderson, Houston, Texas, United States
NEXT Oncology Houston, Houston, Texas, United States
NEXT Oncology Dallas, Irving, Texas, United States
START Mountain Region, LLC, West Valley City, Utah, United States
Contact: Study coordinator (Marie Asay, Director, Nursing) · marie.asay@startresearch.com · 801-907-4770NEXT Oncology Virginia, Fairfax, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
Contact: Study coordinator (Siddhartha Devarakonda, MD) · siddhartha.devarakonda@swedish.org · 206-386-2424
Study leads
Thorsten Graef, MD
Study Director
IDEAYA Biosciences